Bone marrow or peripheral blood as a source of stem cells for allogeneic transplants

Current Opinion in Hematology

Volumn 7, Issue 6, 2000, Pages 343-347

  Bacigalupo, Andrea ^a   Frassoni, Francesco ^a   Van Lint, Maria Teresa ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ALLOGENEIC RESTRICTION; ANTIBIOTIC THERAPY; CANCER RECURRENCE; ERYTHROCYTE TRANSFUSION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; INFECTION; LEUKAPHERESIS; MORTALITY; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

BONE MARROW TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033793179     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200011000-00004     Document Type: Review

References (29)

1. Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor
2. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): Occurrence in an allogeneic donor of peripheral blood stem cells
3. Bone marrow and peripheral blood stem cell donors
4. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor
5. Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections
6. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients
7. A randomised study of allogeneic transplantation with stem cells from blood or bone marrow
8. Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologi malignancies: A single-center experience
9. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow
10. Marrow transplantation for treatment of aplastic anemia: An analysis of factors associated with graft rejection
11. Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplantation
12. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: The effect of leukemic burden, donor HLA-matching, and marrow cell dose
13. Allogeneic blood stem cell transplantation in advanced hematologic cancers
14. A prospective, randomised trial of peripheral blood stem cells (PBSC) or marrow (BM) for patients undergoing allogeneic transplantation for hematologic malignancies
15. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation
16. Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies
17. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors: A case-control study
18. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: A focus on the incidence of graft-vs-host disease and relapse
19. Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: Influence of stem cell source on outcome
20. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation
21. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukemia: First results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation
22. A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies
23. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: A randomised trial
24. Pre-treatment of donor mice with granulocyte colony-stimulating factor polarises donor T lymphocytes toward to type-2 cytosine production and reduces severity of experimental graft-versus host disease
25. High incidence of chronic GvHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematological malignancies
26. Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation
27. Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: Favorable impact of chronic graft-versus-host disease on survival and relapse
28. Malignant neoplasms in long-term survivors of bone marrow transplantation: Late effects working party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group
29. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients